North America Vascular Closure Devices Market Size, Share, Trends & Analysis by Type (Active Approximators, Passive Approximators, External Hemostatic Devices), by Access (Femoral Access, Radial Access), by Procedure (Interventional Cardiology, Interventional Radiology) and Region, with Forecasts from 2024 to 2034.

Market Overview

The North America Vascular Closure Devices (VCD) Market is anticipated to witness significant growth from 2024 to 2034, driven by the increasing volume of minimally invasive cardiovascular procedures, rising prevalence of cardiovascular diseases, and advancements in vascular closure technologies. The market is expected to grow from USD XXX.XX billion in 2024 to USD XX.XX billion by 2034, with a compound annual growth rate (CAGR) of XX.XX%. Key factors contributing to this growth include:

• Increasing Demand for Minimally Invasive Procedures: The growing adoption of interventional cardiology and radiology procedures is driving the demand for vascular closure devices, as they enhance patient recovery by ensuring rapid hemostasis.

• Technological Innovations in Vascular Closure Devices: Continuous advancements in VCD technology, including active and passive approximators, are improving the efficiency of procedures, thus promoting market growth.

• Rising Incidence of Cardiovascular Diseases: The prevalence of heart diseases and associated risk factors such as hypertension, obesity, and diabetes is increasing, resulting in a higher volume of diagnostic and therapeutic vascular procedures.

Definition and Scope of Vascular Closure Devices

Vascular closure devices (VCDs) are medical tools used to achieve hemostasis after interventional procedures like angiography, angioplasty, or catheter-based treatments. These devices aid in sealing the femoral or radial artery puncture site to prevent excessive bleeding and enable faster patient mobility.

Market Drivers

• Rising Cardiovascular Disease Burden: The increasing prevalence of cardiovascular conditions is leading to a surge in the number of diagnostic and interventional procedures, fueling demand for VCDs.

• Shift Towards Outpatient Settings: The growing trend of performing cardiovascular procedures in outpatient settings due to faster recovery and reduced hospitalization is driving the adoption of vascular closure devices.

• Technological Advancements: Continuous innovation in closure devices, especially with more effective and patient-friendly designs, is enhancing market penetration.

Market Restraints

• High Cost of Vascular Closure Devices: The relatively high cost of advanced closure devices may hinder adoption, particularly in cost-conscious healthcare systems.

• Complications Associated with Device Use: In certain cases, VCDs may lead to complications such as infection or artery damage, potentially limiting their widespread acceptance.

Opportunities

• Growing Adoption of Radial Access: As radial access gains popularity over femoral access in procedures due to reduced complications and faster recovery, it opens new opportunities for specialized radial closure devices.

• Rising Focus on Patient Safety and Convenience: Technological innovations that prioritize safety and reduce recovery time offer significant growth opportunities for manufacturers of vascular closure devices.

• Expanding Use in Interventional Radiology: The growing application of VCDs in interventional radiology, along with interventional cardiology, is expected to broaden the market's scope.

Market Segmentation Analysis

• By Type
○ Active Approximators
○ Passive Approximators
○ External Hemostatic Devices

• By Access
○ Femoral Access
○ Radial Access

• By Procedure
○ Interventional Cardiology
○ Interventional Radiology

Regional Analysis

• United States: The U.S. is projected to dominate the North America VCD market due to its advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and substantial adoption of minimally invasive procedures.

• Canada: Steady market growth is anticipated in Canada, driven by increasing healthcare spending and technological advancements in vascular closure devices.

• Mexico: Mexico's improving healthcare infrastructure and rising awareness of advanced vascular treatments are expected to contribute to the expansion of the VCD market.

The North America Vascular Closure Devices Market is positioned for steady growth, driven by the rising prevalence of cardiovascular diseases, increasing demand for minimally invasive procedures, and advancements in vascular closure technologies. Despite challenges such as high device costs and potential complications, the market holds promising opportunities, particularly in the expanding use of radial access and interventional radiology.

Competitive Landscape

Key players in the North America Vascular Closure Devices Market include:

Abbott Laboratories
Cardinal Health
Terumo Corporation
Teleflex Incorporated
Merit Medical Systems
Medtronic PLC
Vivasure Medical
Vasorum Ltd.
TZ Medical
St. Jude Medical (an Abbott company)

Table of Contents:

1. Introduction
1.1. Definition of Vascular Closure Devices
1.2. Scope of the Report
1.3. Research Methodology

2. Executive Summary
2.1. Key Findings
2.2. Market Snapshot
2.3. Key Trends

3. Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Cardiovascular Diseases
3.1.2. Increasing Number of Minimally Invasive Procedures
3.1.3. Growing Adoption of Vascular Closure Devices in Hospitals
3.2. Market Restraints
3.2.1. High Cost of Vascular Closure Devices
3.2.2. Complications Related to Device Usage
3.2.3. Availability of Alternative Closure Techniques
3.3. Market Opportunities
3.3.1. Technological Advancements in Vascular Closure Devices
3.3.2. Expanding Use of Radial Access in Interventions
3.3.3. Strategic Collaborations and Product Launches

4. North America Vascular Closure Devices Market Analysis
4.1. Market Size and Forecast (2024-2034)
4.2. Market Share Analysis by:
4.2.1. Type
4.2.1.1. Active Approximators
4.2.1.2. Passive Approximators
4.2.1.3. External Hemostatic Devices
4.2.2. Access
4.2.2.1. Femoral Access
4.2.2.2. Radial Access
4.2.3. Procedure
4.2.3.1. Interventional Cardiology
4.2.3.2. Interventional Radiology
4.3. Value Chain Analysis
4.4. SWOT Analysis
4.5. Porter's Five Forces Analysis

5. Regional Market Analysis
5.1. United States
5.1.1. Market Overview
5.1.2. Market Size and Forecast
5.1.3. Key Trends
5.1.4. Competitive Landscape
5.2. Canada
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.2.3. Key Trends
5.2.4. Competitive Landscape
5.3. Mexico
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.3.3. Key Trends
5.3.4. Competitive Landscape

6. Competitive Landscape
6.1. Market Share Analysis of Key Players
6.2. Company Profiles of Key Players
6.2.1. Abbott Laboratories
6.2.2. Cardinal Health
6.2.3. Terumo Corporation
6.2.4. Teleflex Incorporated
6.2.5. Merit Medical Systems
6.2.6. Medtronic PLC
6.2.7. Vivasure Medical
6.2.8. Vasorum Ltd.
6.2.9. TZ Medical
6.2.10. St. Jude Medical (an Abbott company)
6.3. Recent Developments and Innovations
6.4. Strategic Initiatives

7. Future Outlook and Market Forecast
7.1. Market Growth Prospects
7.2. Technological Trends and Innovations
7.3. Investment Opportunities
7.4. Strategic Recommendations

8. Key Insights and Reiteration of Main Findings
9. Future Prospects for the North America Vascular Closure Devices Market

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved